相关实验视频
Updated: Jul 15, 2025

Rescue of Recombinant Newcastle Disease Virus from cDNA
Published on: October 11, 2013
欧比病毒NS4蛋白质在抑制细胞反应方面发挥多种作用
Fauziah Mohd Jaafar1, Mourad Belhouchet2, Baptiste Monsion1
1UMR1161 VIROLOGIE, INRAE, Ecole Nationale Vétérinaire d'Alfort, ANSES, Université Paris-Est, 94700 Maisons-Alfort, France.
甲状病毒非结构蛋白4 (NS4) 作为干扰素对抗剂,帮助病毒在治疗细胞中的复制. 它还与酶3相互作用,这表明它在亡和免疫逃避中发挥作用,从而作为一种毒性因子.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 非结构蛋白4 (NS4) 是由orbiviruses编码的,包括蓝舌病病毒 (BTV) 和大岛病毒 (GIV).
- 众所周知,NS4可以在BTV和非洲马病病毒感染期间抵消干扰素反应.
研究的目的:
- 研究来自BTV和GIV的NS4蛋白的功能性作用.
- 为了确认NS4作为干扰素对手的功能.
- 探索NS4与细胞的相互作用过程,如细胞亡.
主要方法:
- 在用干扰素治疗的细胞中使用疫苗病毒E3L删除突变的复制试验.
- 与BTV NS4与核中的caspase 3共同定位的研究.
- 拉下测试检测具有活性caspase3的蛋白质复合体.
主要成果:
- BTV和GIV NS4蛋白质促进了干扰素治疗细胞中疫苗病毒突变的复制.
- 异位表达的BTV NS4在核中与酶3局部化.
- BTV NS4形成了一个复合体,具有活性酶3.
结论:
- 欧比病毒NS4作为干扰素对手,增强病毒复制的功能.
- NS4与酶3的相互作用表明它在调节亡和/或干扰素反应中的作用.
- 作为一种毒性因子,NS4与哺乳动物细胞中orbivirus病原发生有关.
更多相关视频
12:43Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
06:02Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
Published on: September 13, 2018
相关概念视频
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Viral Structure
Viruses with RNA Genomes
Cell-mediated Immune Responses
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...